You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACRV Award Disclosure
Levin Michaela · SEC Form 4 · Filed Sep 2, 2026
Award
Calculated transaction value
$0
Levin Michaela Chief Business Officer
ACRV
Transaction date
Aug 31, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 2 days later
ACRV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 30,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000905148-26-004065
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acrivon Therapeutics, Inc. ACRV Current | Award | Aug 31, 2026 | $0 |
| Acrivon Therapeutics, Inc. ACRV | Award | Aug 31, 2026 | $0 |